Corixa, Wyeth Lederle deal

CRXA granted Wyeth Lederle expanded access to CRXA's monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi ImmunoChem, which CRXA acquired last year. The expansion includes an oil-bas...